AI/ML Programmable Biomanufacturing Platform
Pioneering Programmable biomaterials for human progress
Our mission is to drive the transition to programmable, high-performance materials. We are dedicated to innovation, delivering sequence-defined biomaterials that empower medical therapeutics and are also applicable to the defense and aerospace sectors with biobased, lightweight, and thermally stable aramid-like copolymers.
1
Step One: Data Foundation
Comprehensive ncAA (non-canonical amino acid) sequence structure v.s. mechanical features database. Utilize diverse ncAA sequence combinations and leverage the Cell-Free Protein Synthesis (CFPS) system to rapidly generate products for systematic feature testing.
2
Step Two: AI/ML Predictive model
Robust computational infrastructure of the design-build-test-learn cycle to identify the optimal biomaterial sequences. Implement advanced AI/ML simulation models to analyze sequence data, molecular structures, and mechanical properties, enabling accurate predictions of tensile strength and biocompatibility.
3
Step Three: Biomanufacture
Cutting-edge microbial system that leverages ncAA expression to produce innovative, polymerized sequence-defined biomaterials. A remarkable and scalable fermentation device to facilitate efficient large-scale production of this transformative material.
Inovative Biomaterials for Demanding Applications
Tailored Innovations for Advanced medical and Defense Uses
Collaborative R&D Programs
Partner with us to develop biocompatible and biodegradable material solutions.
Custom Aramid-like material Synthesis
Bespoke aramid copolymers engineered for optimal aerospace performance.
Scalable Biomanufacturing
Efficient production processes designed for high-volume material needs.
